$NTRA stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $98,897,718 of trading volume.
Here is what we see in our data on $NTRA (you can track the company live on Quiver's $NTRA stock page):$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 203 times in the past 6 months. Of those trades, 0 have been purchases and 203 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 14 sales selling 112,436 shares for an estimated $18,755,165.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 27 sales selling 70,362 shares for an estimated $10,335,759.
- JONATHAN SHEENA has made 0 purchases and 73 sales selling 45,517 shares for an estimated $7,372,537.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 10 sales selling 26,233 shares for an estimated $4,303,818.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 29 sales selling 25,523 shares for an estimated $3,864,243.
- GAIL BOXER MARCUS has made 0 purchases and 18 sales selling 18,795 shares for an estimated $2,879,179.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 23 sales selling 18,232 shares for an estimated $2,629,976.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 8 sales selling 6,217 shares for an estimated $927,245.
- ROWAN E CHAPMAN sold 2,750 shares for an estimated $459,222
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 374 institutional investors add shares of $NTRA stock to their portfolio, and 329 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 3,263,822 shares (+44.3%) to their portfolio in Q2 2025, for an estimated $551,390,088
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,650,073 shares (+15.7%) to their portfolio in Q2 2025, for an estimated $278,763,332
- CITADEL ADVISORS LLC removed 1,301,513 shares (-61.3%) from their portfolio in Q2 2025, for an estimated $219,877,606
- KYNAM CAPITAL MANAGEMENT, LP removed 1,167,570 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $197,249,275
- CAPITAL WORLD INVESTORS added 1,013,229 shares (+255.6%) to their portfolio in Q2 2025, for an estimated $171,174,907
- LORD, ABBETT & CO. LLC removed 736,644 shares (-48.4%) from their portfolio in Q2 2025, for an estimated $124,448,637
- POINTSTATE CAPITAL LP removed 615,287 shares (-81.4%) from their portfolio in Q2 2025, for an estimated $103,946,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTRA Government Contracts
We have seen $343,745 of award payments to $NTRA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MODIFICATION TO EXTEND THE POP FOR SIX (6) MONTHS: $140,595
- TUMOR WHOLE EXOME SEQUENCING (WES) AND PERIPHERAL BLOOD CTDNA TEST TESTING (SINGLE ASSAY) SERVICES AND WES ...: $123,950
- GENETIC TESTING: $79,200
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$NTRA Congressional Stock Trading
Members of Congress have traded $NTRA stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 08/22 and 1 sale worth up to $15,000 on 07/22.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 08/15/2025
- Piper Sandler issued a "Overweight" rating on 08/11/2025
- Barclays issued a "Overweight" rating on 08/08/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
- Evercore ISI Group issued a "Outperform" rating on 07/28/2025
- UBS issued a "Buy" rating on 05/09/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 7 analysts offer price targets for $NTRA in the last 6 months, with a median target of $210.0.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $175.0 on 09/22/2025
- Mason Carrico from Stephens & Co. set a target price of $183.0 on 08/15/2025
- David Westenberg from Piper Sandler set a target price of $220.0 on 08/11/2025
- Luke Sergott from Barclays set a target price of $210.0 on 08/08/2025
- Conor McNamara from RBC Capital set a target price of $255.0 on 08/08/2025
- Daniel Markowitz from Evercore ISI Group set a target price of $170.0 on 07/28/2025
- Elizabeth Garcia from UBS set a target price of $218.0 on 05/09/2025
You can track data on $NTRA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
